Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | 6.2B | 5.3B | 7.2B | 6.7B |
Cost of revenue | 3.0B | 2.6B | 3.5B | 3.2B |
Gross profit | 3.2B | 2.7B | 3.7B | 3.5B |
Operating expense | ||||
Research & development | 1.1B | 1.0B | 1.0B | 991.4M |
Selling general and admin | 277M | 273.3M | 284.1M | 287.8M |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 1.4B | 2.4B | 2.2B |
Non operating interest income | ||||
Income | — | 26.2M | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.8B | 1.4B | 2.4B | 2.2B |
Tax provision | 291.6M | 224M | 385.6M | 343.7M |
Net income | 1.6B | 1.2B | 2.0B | 1.9B |
Basic EPS | 4.0 | 3.1 | 5.2 | 4.8 |
Diluted EPS | 4.0 | 3.1 | 5.2 | 4.8 |
Basic average shares | 393.2M | 393.4M | 393.4M | 393.4M |
Diluted average shares | 393.5M | 393.7M | 393.8M | 393.7M |
EBITDA | 2.1B | 1.6B | 2.8B | 2.4B |
Net income from continuing op. | 1.6B | 1.2B | 2.0B | 1.9B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |